Table 1

Baseline Characteristics of Patients Participating in a Trial of Short Message Service Reminders for Seasonal Influenza Vaccination, Western Australia, 2016

CharacteristicIntervention Group No. (%)Control Group No. (%)P Value
Total6,1776,177
Sex
 Male2,927 (47.4)2,921 (47.3)
 Female3,241 (52.5)3,249 (52.6)
 Not provided9 (0.1)7 (0.1).90
Age group, y
 <51,530 (24.8)1,487 (24.1)
 5–17403 (6.5)380 (6.1)
 18–642,463 (39.9)2,478 (40.1)
 ≥651,781 (28.8)1,832 (29.7).20
Race
 Indigenous480 (7.8)517 (8.4)
 Non-Indigenous2,979 (48.2)3,004 (48.6)
 Not indicated in patient record2,718 (44.0)2,656 (43.0).34
Preexisting chronic medical conditions
 Diabetes874 (14.1)876 (14.2)
 Chronic heart disease387 (6.2)421 (6.8)
 Asthma1,935 (31.3)1,875 (30.3)
 Chronic obstructive pulmonary disease179 (2.9)169 (2.7)
 Impaired immunity148 (2.4)132 (2.1).58
Pregnanta
 Yes124 (14.9)115 (13.3)
 No709 (85.1)747 (86.7).47
Record of influenza vaccine with practice
 Yes1,998 (32.3)2,011 (32.6)
 No4,179 (67.7)4,166 (67.4).80
  • a Among reproductive women aged 19 to 44 years (n = 833 in intervention group; n = 862 in control group).